CONTACT | Media: +31.20.550.4488 (Amsterdam), +32.2.509.1392 (Brussels) +351.217.900.029 (Lisbon), +44.20.7379.2789 (London) +1.212.656.2411 (New York), +33.1.49.27.11.33 (Paris)

CONTACT | Investor Relations: +1.212.656.5700 (New York) +33.1.49.27.58.60 (Paris)

NYSE Euronext Announces Trading Volumes for April 2012

Global Derivatives ADV in April Down 7% Year-over-Year; Up 9% from 1Q12 Levels #1 in U.S. Equity Options in April; Record Monthly Market Share for NYSE Amex Options April European Cash ADV Up 23% and U.S. Cash ADV Down 13% Year-over-Year

May 8, 2012 – NYSE Euronext (NYX) today announced trading volumes for its global derivatives and cash equities exchanges for April 2012¹ . Trading volumes were mixed both year-over-year and month-over-month across most venues, but reflected some strengthening relative to weak first quarter 2012 levels. Global derivatives average daily volume ("ADV") of 8.2 million contracts in April 2012 decreased 6.9% versus the prior year, but increased 1.4% from March 2012 and increased 9.0% from first quarter 2012 levels. European cash trading ADV in April increased 22.8% versus the prior year, increased 14.8% from March 2012 levels and increased 17.8% from first quarter 2012 levels. U.S. cash trading ADV decreased 13.3% and 2.5% from April 2011 and March 2012 levels, respectively, and declined 3.6% from first quarter 2012 levels.

Highlights

NYSE Euronext global derivatives ADV in April 2012 of 8.2 million contracts decreased 6.9% compared to April 2011, but increased 1.4% from March 2012 levels and were up 9.0% from first quarter 2012 levels.
NYSE Euronext European derivatives products ADV in April 2012 of 4.3 million contracts decreased 9.6% compared to April 2011, but increased 9.1% from March 2012 and were up 28.2% from first quarter 2012 levels. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV decreased 2.8% compared to April 2011, were in-line with March 2012 and increased 5.3% from first quarter 2012 levels.
NYSE Euronext U.S. equity options ADV of 3.9 million contracts in April 2012 decreased 3.3% compared to April 2011 levels, decreased 4.9% from March 2012 and decreased 5.5% from first quarter 2012 levels. NYSE Euronext's U.S. options exchanges accounted for 26.4% of total U.S. consolidated equity options trading in April 2012, up from 25.7% in April 2011 and up from 26.0% in March 2012. NYSE Euronext was the #1 U.S. equity options exchange operator in April 2012 and NYSE Amex Options recorded record monthly market share of 15.8%.
NYSE Liffe U.S. ADV of approximately 61,500 contracts decreased from 91,700 contracts in April 2011 and decreased from 104,900 contracts in March 2012.

¹ All NYSE Euronext derivatives transactions count buy and sell orders together as a single transaction. NYSE Euronext European equities transactions count each buy and sell order as separate transactions, NYSE Euronext U.S. equities transactions count buy and sell orders together as a single transaction.

NYSE Euronext European cash products ADV of 1.9 million transactions in April 2012 increased 22.8% compared to April 2011 and increased 14.8% from March 2012 levels. European cash products ADV in April 2012 was 17.8% above first quarter 2012 levels.
NYSE Euronext U.S. cash products handled ADV of 1.7 billion shares in April 2012 decreased 13.3% compared to April 2011 and decreased 2.5% compared to March 2012. U.S. cash products handled ADV in April 2012 was 3.6% below first quarter 2012 levels. NYSE Euronext's Tape A matched market share in April 2012 was 31.3%, down from 33.3% in April 2011, in-line with March 2012 and above the 30.6% recorded in the first quarter of 2012.
There were a total of 19 trading days in Europe and 20 trading days in the U.S. in April 2012 and April 2011.

Derivatives Trading

European Derivatives

NYSE Euronext European derivatives products ADV in April 2012 of 4.3 million contracts decreased 9.6% compared to April 2011, but increased 9.1% from March 2012 levels and was up 28.2% from first quarter 2012 levels.
The 4.3 million in European derivatives futures and options contracts ADV in April 2012 consisted of 2.8 million contracts executed through our full-service LIFFE CONNECT trading platform and 1.5 million contracts, or 34.4%, executed through Bclear, NYSE Liffe's trade administration and clearing service for OTC products. Excluding Bclear, NYSE Liffe's trade administration and clearing service for OTC products, European derivatives products ADV decreased 2.8% compared to April 2011, were in-line with March 2012 and increased 5.3% from first quarter 2012 levels.
Year-to-date, European derivatives products ADV of 3.5 million contracts was 23.8% below prior year levels. The 3.5 million in futures and options contracts ADV year-todate consisted of 2.7 million contracts executed through LIFFE CONNECT trading platform and 0.8 million contracts, or 24.1%, executed through Bclear.
Total fixed income products ADV of 1.8 million contracts in April 2012 decreased 7.1% from April 2011, decreased 4.5% from March 2012, but were 1.0% above first quarter 2012 levels. Year-to-date, total fixed income products ADV of 1.8 million contracts was 29.5% below prior year levels.
Total equity products (including Bclear) ADV of 2.4 million contracts in April 2012 decreased 11.7% compared to April 2011, but increased 22.6% from March 2012. The 2.4 million contracts in equity products ADV consisted of 1.8 million contracts in individual equity products ADV and 0.6 million contracts in equity index products ADV. The 2.4 million contracts in individual equity products ADV consisted of 1.3 million in futures contracts, which represented a 24.6% decrease compared to April 2011 and 0.5 million in options contracts, which represented a 4.8% increase compared to April 2011. The average net rate per contract for individual equity futures contracts is significantly lower than other European derivatives products. Year-to-date, total equity products ADV of 1.7 million contracts was 17.6% below prior year levels.
Total commodities products ADV of approximately 81,000 contracts in April 2012 increased 4.7% compared to April 2011 and decreased 1.2% compared to March 2012. Year-to-date, total commodities product ADV of 81,000 contracts was 4.9% below prior year levels.

U.S. Derivatives

• NYSE Euronext U.S. equity options ADV of 3.9 million contracts in April 2012 decreased 3.3% compared to April 2011, decreased 4.9% compared to March 2012 and were 5.5%

below first quarter 2012 levels. Year-to-date, U.S. equity options ADV of 4.1 million contracts was 5.7% below prior year levels.

Total U.S. consolidated equity options ADV decreased 5.9% to 14.8 million contracts in April 2012 compared to April 2011 and decreased 6.6% compared to March 2012. Yearto-date, U.S. consolidated equity options ADV of 15.6 million contracts was 7.7% below prior year levels.
NYSE Euronext's U.S. options exchanges accounted for 26.4% of the total U.S. consolidated equity options trading in April 2012, up from 25.7% in April 2011 and up from 26.0% in March 2012. NYSE Euronext was the #1 U.S. equity options exchange operator in April 2012 and NYSE Amex Options recorded record monthly market share of 15.8%.
NYSE Liffe U.S. ADV of approximately 61,500 contracts decreased from 91,700 contracts in April 2011 and decreased from 104,900 contracts in March 2012. Year-to-date, U.S. futures and futures options ADV of 87,700 contracts was 131.7% above prior year levels.

Cash Trading

European Cash

NYSE Euronext European cash products ADV of 1.9 million transactions in April 2012 increased 22.8% compared to April 2011, increased 14.8% compared to March 2012 and was 17.8% above first quarter 2012 levels.
Year-to-date, European cash products ADV of 1.6 million transactions was 5.2% below prior year levels.

U.S. Cash

NYSE Euronext U.S. cash products handled ADV in April 2012 decreased 13.3% to 1.7 billion shares compared to April 2011, decreased 2.5% from March 2012 and was 3.6% below first quarter 2012 levels.
Year-to-date, U.S. cash products handled ADV was 1.8 billion shares, down 20.7% from prior year levels.
NYSE Euronext's Tape A matched market share in April 2012 was 31.3%, down from 33.3% in April 2011, in-line with March 2012 and above the 30.6% recorded in the first quarter of 2012.

Exchange Traded Funds

NYSE Euronext U.S. matched exchange-traded funds ADV (included in volumes for Tape B and Tape C) of 216 million shares in April 2012 decreased 10.6% compared to April 2011, decreased 2.7% compared to March 2012 and decreased 2.3% compared to the first quarter of 2012.
Year-to-date, NYSE Euronext U.S. matched exchange-traded funds ADV of 220 million shares was 19.4% below prior year levels.

Please click here for the Monthly Transaction Activity Data Table.

About NYSE Euronext

NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixedincome and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets — the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca — represent one-third of the worlds equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and

the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index. For more information, please visit: www.nyx.com.

Disclaimer and Cautionary Note Regarding Forward-Looking Statements

This press release may contain forward-looking statements, including forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, statements concerning NYSE Euronext's plans, objectives, expectations and intentions and other statements that are not historical or current facts. Forward-looking statements are based on NYSE Euronext's current expectations and involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in such forward-looking statements. Factors that could cause NYSE Euronext's results to differ materially from current expectations include, but are not limited to: NYSE Euronext's ability to implement its strategic initiatives, economic, political and market conditions and fluctuations, government and industry regulation, interest rate risk and U.S. and global competition, and other factors detailed in NYSE Euronext's 2011 Annual Report on Form 10-K and other periodic reports filed with the U.S. Securities and Exchange Commission or the French Autorité des Marchés Financiers. In addition, these statements are based on a number of assumptions that are subject to change. Accordingly, actual results may be materially higher or lower than those projected. The inclusion of such projections herein should not be regarded as a representation by NYSE Euronext that the projections will prove to be correct. This press release speaks only as of this date. NYSE Euronext disclaims any duty to update the information herein.

NYSE Euronext Monthly Volume Summary

	Average Daily Volume			Total Volume			Average Daily Volume		Total Volume
								% Chg vs.		% Chg vs.
(Unaudited; contracts in thousands)	Apr-12	Apr-11	% Chg	Apr-12	Apr-11	% Chg	YTD 2012	YTD 2011	YTD 2012	YTD 2011

Number of Trading Days - European Markets Number of Trading Days - U.S. Markets	19 20	19 20		19 20	19 20		84 82		84 82
European Derivatives Products	4,270	4,721	-9.6%	81,127	89,699	-9.6%	3,544	-23.8%	297,722	-22.9%
of which Bclear	1,471		1,842 -20.1%	27,945		34,990 -20.1%	853	-16.0%	71,675	-15.0%
Total Fixed Income Products	1,792	1,929	-7.1%	34,049	36,659	-7.1%	1,778	-29.5%	149,377	-28.7%
Short Term Interest Rate Products	1,665	1,817	-8.3%	31,636	34,516	-8.3%	1,632	-31.9%	137,074	-31.1%
Medium and Long Term Interest Rate Products 1	127	113	12.7%	2,414	2,143	12.7%	146	15.1%	12,303	16.5%
Total Equity Products 2	2,397		2,714 -11.7%	45,538		51,570 -11.7%	1,685	-17.6%	141,512	-16.6%
	1,847			35,085
Individual Equity Products Futures	1,325		2,254 -18.1% 1,756 -24.6%	25,173		42,828 -18.1% 33,369 -24.6%	1,206 695	-19.2% -17.8%	101,328 58,347	-18.2% -16.8%
Options	522	498	4.8%	9,913	9,459	4.8%	512	-20.9%	42,980	-20.0%
Equity Index Products	550	460	19.6%	10,453	8,742	19.6%	478	-13.4%	40,185	-12.3%
of which Bclear	1,471		1,842 -20.1%	27,945		34,990 -20.1%	853	-16.0%	71,675	-15.0%
Individual Equity Products	1,409		1,785 -21.1%	26,765		33,914 -21.1%	783	-16.8%	65,763	-15.8%
Futures	1,253		1,701 -26.3%	23,816		32,319 -26.3%	672	-18.8%	56,476	-17.9%
Options	155 62	84 57	84.9%	2,948 1,180	1,594 1,076	84.9%	111	-1.4%	9,287	-0.2%
Equity Index Products			9.7%			9.7%	70	-6.7%	5,912	-5.5%
Commodity Products	81	77	4.7%	1,539	1,470	4.7%	81	-4.9%	6,833	-3.7%
U.S. Derivatives Products
Equity Options 3
NYSE Euronext Options Contracts	3,903	4,034	-3.3%	78,050	80,687	-3.3%	4,073	-5.7%	333,973	-5.7%
Total Consolidated Options Contracts	14,772	15,705	-5.9%	295,434 314,103		-5.9%	15,609	-7.7%	1,279,942	-7.7%
NYSE Group Share of Total	26.4%	25.7%		26.4%	25.7%		26.1%	0.6%	26.1%	0.6%
NYSE Liffe U.S.
Futures and Futures Options Volume*	61.5		91.7 -33.0%	1,291		1,834 -29.6%	87.7	131.7%	7,452.0	134.4%

European Cash Products (trades in thousands)	1,865	1,519	22.8%	35,444	28,860	22.8%	1,647	-5.2%	138,371	-4.1%
Equities Exchange-Traded Funds	1,810 16	16	1,461 23.9% -0.3%	34,385 301	302	27,757 23.9% -0.3%	1,593 15	-4.6% -24.1%	133,824 1,242	-3.4% -23.2%
Structured Products	35	37	-5.7%	658	697	-5.7%	34	-19.9%	2,893	-19.0%
Bonds	5	5	-3.0%	101	104	-3.0%	5	-9.9%	412	-8.8%
U.S. Cash Products (shares in millions) 5	1,719	1,982	-13.3%	34,378	39,637	-13.3%	1,768	-20.7%	144,935	-20.7%
NYSE Listed (Tape A) Issues 4

Handled Volume 5 Matched Volume 6	1,238 1,170	1,409 1,330	-12.1% -12.0%	24,760 23,408	28,179 26,610	-12.1% -12.0%	1,266 1,194	-21.1% -21.3%	103,782 97,939	-21.1% -21.3%
Total NYSE Listed Consolidated Volume	3,743	3,995	-6.3%	74,868	79,902	-6.3%	3,886	-12.2%	318,667	-12.2%
Share of Total Consolidated Volume
Handled Volume 5	33.1%	35.3%	-2.2%	33.1%	35.3%	-2.2%	32.6%	-3.7%	32.6%	-3.7%
Matched Volume 6	31.3%	33.3%	-2.0%	31.3%	33.3%	-2.0%	30.7%	-3.5%	30.7%	-3.5%
NYSE Arca & Amex (Tape B) Listed Issues

Handled Volume 5 Matched Volume 6	253 226	296 265	-14.5% -14.5%	5,067 4,530	5,923 5,295	-14.5% -14.5%	262 234	-21.5% -21.8%	21,507 19,200	-21.5% -21.8%
Total NYSE Arca & Amex Listed Consolidated Volume	1,094	1,154	-5.2%	21,874	23,081	-5.2%	1,116	-14.4%	91,494	-14.4%
Share of Total Consolidated Volume
Handled Volume 5	23.2%	25.7%	-2.5%	23.2%	25.7%	-2.5%	23.5%	-2.2%	23.5%	-2.2%
Matched Volume 6	20.7%	22.9%	-2.2%	20.7%	22.9%	-2.2%	21.0%	-2.0%	21.0%	-2.0%
Nasdaq Listed (Tape C) Issues
Handled Volume 5	228	277	-17.8%	4,552	5,534	-17.8%	240	-17.6%	19,646	-17.6%
Matched Volume 6	192	234	-18.0%	3,832	4,672	-18.0%	203	-18.0%	16,608	-18.0%
Total Nasdaq Listed Consolidated Volume	1,704	1,928	-11.6%	34,074	38,557	-11.6%	1,773	-12.3%	145,404	-12.3%
Share of Total Consolidated Volume
Handled Volume 5	13.4%	14.4%	-1.0%	13.4%	14.4%	-1.0%	13.5%	-0.9%	13.5%	-0.9%
Matched Volume 6	11.2%	12.1%	-0.9%	11.2%	12.1%	-0.9%	11.4%	-0.8%	11.4%	-0.8%
Exchange-Traded Funds 5,7
Handled Volume 5	242	271	-10.5%	4,846	5,413	-10.5%	247	-18.9%	20,253	-18.9%
Matched Volume 6	216	242	-10.6%	4,327	4,838	-10.6%	220	-19.4%	18,045	-19.4%
Total ETF Consolidated Volume	1,074	1,061	1.3%	21,487	21,216	1.3%	1,082	-9.9%	88,685	-9.9%
Share of Total Consolidated Volume
Handled Volume 5	22.6%	25.5%	-2.9%	22.6%	25.5%	-2.9%	22.8%	-2.5%	22.8%	-2.5%
Matched Volume 6	20.1%	22.8%	-2.7%	20.1%	22.8%	-2.7%	20.3%	-2.4%	20.3%	-2.4%

1 Data includes currency products.

2 Includes Bclear trading Includes all trading activities for Bclear, NYSE Liffe's clearing service for wholesale derivatives.

3 Includes trading in U.S. equity options contracts, not equity-index options.

4 Includes all volume executed in NYSE Group crossing sessions.

5 Represents the total number of shares of equity securities and ETFs internally matched on the NYSE Group's exchanges or routed to and

executed at an external market center. NYSE Arca routing includes odd-lots.

Represents the total number of shares of equity securities and ETFs executed on the NYSE Group's exchanges.

7 Data included in previously identified categories.

ADVs calculated with the appropriate number of NYSE Liffe U.S. trading days.

Source: NYSE Euronext, Options Clearing Corporation and Consolidated Tape as reported for equity securities.

All trading activity is single-counted, except European cash trading which is double counted to include both buys and sells.

Please note: Nasdaq Listed Consolidated Volumes have been adjusted for Nasdaq's April 5th UTDF trade reporting issue.

AI Terminal

Euronext N.V.

3839_iss_2012-05-08_fb55e236-fd6c-4b5d-be54-b4939651e3bd.pdf